900 Hospital of the Joint ( Site 0197)

Fuzhou, Fujian 350025

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma

Studies at this site

• Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937) — Completed